Table 3.
Changes in iron status and renal function biomarkers in the study groups.
| Parameters | Eprex | Pastopoitin | p-Value |
|---|---|---|---|
| Iron (μg/dL) | |||
| Baseline | 110.72 ± 119.11 | 101.73 ± 59.73 | 0.31 |
| Endpoint | 85.22 ± 17.7 | 90.66 ± 34.82 | 0.06 |
| Ferritin (ng/mL) | |||
| Baseline | 443.53 ± 283.61 | 430.66 ± 275.63 | 0.53 |
| Endpoint | 472.96 ± 284.54 | 426.61 ± 282.29 | 0.84 |
| TIBC (μg/dL) | |||
| Baseline | 280.69 ± 57.18 | 300.84 ± 75.66 | 0.08 |
| Endpoint | 290.04 ± 41.96 | 302.06 ± 74.13 | 0.07 |
| BUN (mg/dL) | |||
| Baseline | 63.31 ± 27.59 | 57.9 ± 22.8 | 0.16 |
| Endpoint | 65.56 ± 23.89 | 57.74 ± 18.52 | 0.9 |
| Creatinine (mg/dL) | |||
| Baseline | 9.20 ± 3.24 | 8.92 ± 2.79 | 0.4 |
| Endpoint | 10.09 ± 3.23 | 9.63 ± 2.93 | 0.95 |
TIBC: total iron binding capacity; BUN: blood urea nitrogen.